ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,703Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 780

$712K Total Retail Price of All Prescriptions

Rank: 159 out of 780

555 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 15,539 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 912 821 1 3
SIMVASTATIN 688 663 2 2
LEVOTHYROXINE SODIUM 564 541 3 5
FUROSEMIDE 533 508 4 7
WARFARIN SODIUM 358 344 5 24
LOSARTAN POTASSIUM 324 293 6 18
TRAMADOL HCL 317 285 7 15
AMLODIPINE BESYLATE 316 298 8 4
HYDROCHLOROTHIAZIDE 316 312 8 10
CITALOPRAM HBR 304 279 10 23
GLIMEPIRIDE 289 266 11 30
POTASSIUM CHLORIDE 274 255 12 11
METOPROLOL SUCCINATE 252 242 13 20
ZOLPIDEM TARTRATE 240 230 14 17
METFORMIN HCL 235 220 15 8
SPIRONOLACTONE 227 214 16 53
HYDROCODONE-ACETAMINOPHEN 217 195 S3 17 1
ATORVASTATIN CALCIUM 202 173 18 12
METOPROLOL TARTRATE 200 180 19 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 200 189 19 26
LOSARTAN-HYDROCHLOROTHIAZIDE 190 185 21 33
ATENOLOL 190 186 21 21
POLYETHYLENE GLYCOL 3350 189 188 23 79
CLONIDINE HCL 187 178 24 28
PANTOPRAZOLE SODIUM 181 163 25 25
ALLOPURINOL 175 172 26 29
AZITHROMYCIN 174 157 27 38
LISINOPRIL 171 155 28 6
DONEPEZIL HCL 169 169 29 31
TAMSULOSIN HCL 145 131 30 36
DIGOXIN 145 121 30 56
SYNTHROID 138 138 32 77
PREDNISONE 131 128 33 40
PRAVASTATIN SODIUM 131 130 33 9
CRESTOR 129 125 35 32
CHLORTHALIDONE 128 126 36 142
RISPERIDONE 127 126 37 98
LABETALOL HCL 122 119 38 159
TRAMADOL HCL-ACETAMINOPHEN 120 111 39 140
PROAIR HFA 109 84 40 62
SERTRALINE HCL 109 87 40 27
DOXAZOSIN MESYLATE 106 106 42 97
RAMIPRIL 105 97 43 70
METHYLPREDNISOLONE 104 95 44 92
NEXIUM 103 96 45 22
GABAPENTIN 102 96 46 13
GEMFIBROZIL 101 93 47 104
NAMENDA 100 100 48 46
ISOSORBIDE MONONITRATE ER 97 97 49 60
FAMOTIDINE 95 87 50 86
MELOXICAM 93 93 51 16
LOVASTATIN 93 81 51 47
JANUVIA 91 76 53 85
TRIAMTERENE-HCTZ 90 90 54 37
AMIODARONE HCL 86 86 55 139
HYDRALAZINE HCL 84 84 56 54
MIRTAZAPINE 78 78 57 58
CLOPIDOGREL 76 76 58 34
NIFEDIPINE ER 75 75 59 115
ALENDRONATE SODIUM 74 74 60 44
ROPINIROLE HCL 72 72 61 87
PROBENECID-COLCHICINE 72 72 61 314
CARBIDOPA-LEVODOPA 69 61 63 124
BISOPROLOL FUMARATE 68 68 64 143
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 67 65 95
INSULIN SYRINGE 66 57 66 80
DILTIAZEM 24HR CD 66 66 66 138
VERAPAMIL ER 66 63 66 78
KLOR-CON M20 65 65 69 57
LANTUS 63 63 70 71
LIPITOR 62 61 71 175
SINGULAIR 62 55 71 73
BENAZEPRIL HCL 60 58 73 59
PHENYTOIN SODIUM EXTENDED 60 43 73 128
CARVEDILOL 59 59 75 14
FINASTERIDE 58 58 76 150
CELEBREX 58 58 76 89
AMITRIPTYLINE HCL 58 49 R 76 48
PLAVIX 57 57 79 45
MECLIZINE HCL 56 56 80 83
ZETIA 56 56 80 94
DIOVAN 54 54 82 55
PAROXETINE HCL 52 37 83 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.